GCP is an international norm for clinical trials that guarantees that the rights, wellbeing, and prosperity of clinical trial subjects are ensured and that the clinical trial information is believable. Different authoritative prerequisites exist for [https://cannabisindustryjournal.com/feature_article/hazard-analysis-and-critical-control-points-haccp-for-the-cannabis-industry-part-1l]GCP[/https://cannabisindustryjournal.com/feature_article/hazard-analysis-and-critical-control-points-haccp-for-the-cannabis-industry-part-1] training from a national level to a global. For instance, in the United Kingdom, guideline 28 of the UK SI 2004/1031 states that "no individual will direct a clinical trial… in any case than as per the conditions and standards of GCP." From a global viewpoint, the International Conference on Harmonization (ICH) Guideline for Good Clinical Practice §2.8. states: "Each individual involved in leading a trial ought to be qualified by instruction, training, and experience to play out their separate task(s)." This implies each individual involved in directing a clinical trial must get training in GCP.